Clinical Trial Update: PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating PET imaging of PDE4 in brain and peripheral organs for McCune-Albright syndrome; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mccune-albright Syndrome
• Nervous System Disease

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Nervous System Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-19